Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo Biloba for Chemotherapy-Related Cognitive Dysfunction
NCT00046891Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Dec 2002
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ginkgo biloba extract in cognitive impairment, sponsored by Cancer and Leukemia Group B. Started Dec 2002; status: completed.
02
Drugs
ginkgo biloba extract
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT00046891.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00046891.